Table 5. Cost of mental health disorders and cost-effectiveness of treatments
Mental Health Outcome | Estimated Economic Burden | Estimated Cost-Effectiveness of Treatment | |
|
|||
Depression (MDD) | $210.5 bn(2015) | $2.3-$2.6 saved per $1 spent | |
Anxiety | $33.71 bn(2013) | 2.7美元-$3.0 saved per $1 spent3 | |
Opioids | $78.5 bn(2016) | ||
Drugs | $193 bn(2011) | 每花费1美元3.77美元了 | |
Alcohol | $249 bn(2015) | ||
Suicide | $93.5 bn(2015) | $2.43 saved per $1 spent | |
|
Sources: $210.5bn- Greenberg
1;$33.71bn- Shirneshan;
278.5bn- Florence
3;$193bn- NDIC
4;$249bn- Sacks
5;$93.5bn- Stone
6;$2.3-$2.6 Chisholm
7;2.7美元-$3.0 Chisholm
8;$3.77- Aos
9;2.43- Richardson
10
Note: The Estimate Cost Effectiveness of Treatment statistics are based on treatments such as psychosocial treatment, psychosocial treatment plus antidepressants, post-discharge follow-up calls, cognitive behavioral therapy, and drug counseling, to note a few. Exact treatments vary by statistic. Please refer to the appropriate references for more information.
Note: The Estimate Cost Effectiveness of Treatment statistics are based on treatments such as psychosocial treatment, psychosocial treatment plus antidepressants, post-discharge follow-up calls, cognitive behavioral therapy, and drug counseling, to note a few. Exact treatments vary by statistic. Please refer to the appropriate references for more information.
For more information on this topic pleaseview the PDF of the full report.
Footnotes
- Greenberg P.E., Fournier A.A., Sisitsky T., Pike C.T, & Kessler R.C. (2015). The economic burden of adults with major depressive disorder in the United States (2005 and 2010). Journal of Clinical Psychiatry. doi:10.4088/JCP.14m09298. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pubmed/25742202
- Shirneshan E. (2013). Cost of Illness Study of Anxiety Disorders for the Ambulatory Adult Population of the United States (Doctor of Philosophy), University of Tennessee Health Science Center, Retrieved fromhttps://dc.uthsc.edu/cgi/viewcontent.cgi? article=1370&context=dissertations
- Florence C.S., Zhou C., Luo F., & Xu L. (2016). The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013. Medical Care. doi:10.1097/MLR. 0000000000000625. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pubmed/27623005
- National Drug Intelligence Center. (2011). National Drug Threat Assessment. Retrieved fromhttps://www.justice.gov/archive/ndic/pubs44/44849/44849p.pdf.
- Sacks J.J., Gonzales K.R., Bouchery E.E., Tomedi L.E., & Brewer R.D. (2015). 2010 National and State Costs of Excessive Alcohol Consumption. American Journal of Preventive Medicine. doi:doi: 10.1016/j.amepre.2015.05.031. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pubmed/ 26477807
- Stone D., Holland K., Bartholow B., Crosby A., Davis S., & Wilkins N. (2017). Preventing Suicide: A Technical Package of Policy, Programs, and Practices. . Retrieved fromhttps://www.cdc.gov/violenceprevention/pdf/suicidetechnicalpackage.pdf
- Chisholm D., Sweeny K., Sheehan P., Rasmussen B., Smit F., Cuijpers P., & S., S. (2016). Scalingup treatment of depression and anxiety: a global return on investment analysis. The Lancet Psychiatry. doi:https://doi.org/10.1016/S2215-0366(16)30024-4. Retrieved fromhttps://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30024-4/fulltext
- Chisholm D., Sweeny K., Sheehan P., Rasmussen B., Smit F., Cuijpers P., & S., S. (2016). Scalingup treatment of depression and anxiety: a global return on investment analysis. The Lancet Psychiatry. doi:https://doi.org/10.1016/S2215-0366(16)30024-4. Retrieved fromhttps://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30024-4/fulltext
- Aos, S., Mayfield, J., Miller, M., & Yen, W. (2006). Evidence-Based Treatment of Alcohol, Drug, and Mental Health Disorders: Potential Benefits, Costs, and Fiscal Impacts for Washington State. Retrieved from http://www.wsipp.wa.gov/ReportFile/945/Wsipp_Evidence-based-Treatment-of-Alcohol-Drug-and-Mental-Health-Disorders-Potential-Benefits-Costs-and-Fiscal-Impacts-for-Washington-State_Full-Report.pdf
- Richardson J.S., Mark T.L., & R., M. (2014). The Return on Investment of Postdischarge Follow-Up Calls for Suicidal Ideation or Deliberate Self-Harm. Psychiatry Online. doi:https://doi.org/10.1176/appi.ps.201300196. Retrieved fromhttps://ps.psychiatryonline.org/doi/full/10.1176/appi.ps.201300196